Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Rev. chil. obstet. ginecol ; 67(5): 377-380, 2002. ilus, tab
Artículo en Español | LILACS | ID: lil-627335

RESUMEN

Se presentan los resultados de 140 muestras histológicas tomadas en pacientes con cáncer de mama para determinar su concentración de receptores de estrógenos. Destaca la importancia, frecuencia de positividad para receptores de estrógenos en todos los tipos histológicos.


We've analized the resuls from 140 histologic samples taken to patients with breast cancer in order to find its concentration of estrogen receptors. We notice a high frecuency of positive indexes for estrogen receptors in all histologic types.


Asunto(s)
Humanos , Masculino , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Neoplasias de la Mama/patología , Receptores de Estrógenos , Biopsia , Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/metabolismo , Inmunohistoquímica
2.
Rev. méd. Chile ; 127(4): 399-409, abr. 1999. ilus, tab
Artículo en Español | LILACS | ID: lil-243910

RESUMEN

Background: Recent studies suggest that polymorphisms associated to the aldose reductase gene could be related to early retinopathy in noninsulin dependent diabetics (NIDDM). There is also new interest on the genetic modulation of coagulation factors in relation to this complication. Aim: To look for a possible relationship between the rate of appearance of retinopathy and the genotype of (AC)n polymorphic marker associated to aldose reductase gene. Patients and methods: A random sample of 27 NIDDM, aged 68.1 ñ 10.6 years, with a mean diabetes duration of 20.7 ñ 4.8 years and a mean glycosilated hemoglobin of 10.6 ñ 1.6 percent, was studied. The genotype of the (AC)n, polymorphic marker associated to the 5Õ end of the aldose reductase (ALR2) gene was determined by 32P-PCR plus sequenciation. Mutations of the factor XIII-A gene were studied by single stranded conformational polymorphism, sequenciation and restriction fragment length polymorphism. Results: Four patients lacked the (AC)24 and had a higher rate of appearance of retinopathy than patients with the (AC)24 allele (0.0167 and 0.0907 score points per year respectively, p=0.047). Both groups had similar glycosilated hemoglobin (11.7 ñ 0.2 and 10.5 ñ 1.6 percent respectively). Factor XIII gene mutations were not related to the rate of appearance of retinopathy. Conclusions: Our data suggest that the absence of the (AC)24 allele of the (AC)n polymorphic marker associated to the 5Õ end of the aldose reductase gene, is associated to a five fold reduction of retinopathy appearance rate


Asunto(s)
Humanos , Aldehído Reductasa/genética , Retinopatía Diabética/genética , Hemoglobina Glucada , Diabetes Mellitus Tipo 2/complicaciones , Electroforesis , Alelos , Biomarcadores , Polimorfismo Genético , Retinopatía Diabética/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA